iRadimed Cash Flow Statement
NASDAQ: IRMDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
iRadimed free cash flow
In fiscal 2025, iRadimed generated $24.9 million of operating cash flow and spent $7.8 million on capital expenditures. That left free cash flow of $17.2 million, a free-cash-flow margin of 20.5% of revenue. Free cash flow was down 2.5% from the prior year's $17.6 million.
iRadimed returned $15.0 million to shareholders through dividends, equal to 88% of free cash flow. Free cash flow covered dividend payments 1.1 times.
Summary generated from market data by MetaCap's automated system. Methodology
iRadimed cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 22.48M | 19.23M | 17.19M | 12.83M | 9.33M | 1.37M | 9.63M | 6.30M | 499.76K | 7.21M |
| Net Income growth (YoY) | +16.88% | +11.87% | +34.02% | +37.56% | +581.19% | -85.79% | +52.79% | +1161.29% | -93.07% | -4.19% |
| Depreciation & Amortization | 1.17M | 818.00K | 765.18K | 670.67K | 1.41M | 1.34M | 1.24M | 1.11M | 1.31M | 955.81K |
| Stock-Based Compensation | 2.92M | 2.52M | 2.19M | 1.39M | 1.46M | 3.96M | 1.85M | 1.76M | 2.45M | 1.84M |
| Change in Working Capital | -2.92M | 3.90M | -5.76M | -8.29M | -863.83K | 1.93M | -2.31M | -475.08K | -128.38K | 199.73K |
| Operating Cash Flow | 24.95M | 25.62M | 13.47M | 10.04M | 11.26M | 5.82M | 10.23M | 7.38M | 3.42M | 9.41M |
| Capital Expenditures | -7.76M | -8.01M | -7.44M | -823.02K | -482.32K | -443.00K | -368.28K | -228.31K | -775.57K | -780.81K |
| Investing Cash Flow | -8.42M | -8.82M | -8.01M | -1.37M | 648.24K | 246.97K | 3.20M | 1.52M | -1.02M | -1.94M |
| Dividends Paid | -15.04M | -13.68M | -13.22M | -12.56M | — | — | — | — | — | — |
| Share Repurchases | — | — | — | — | — | — | — | — | -1.82M | -9.97M |
| Financing Cash Flow | -17.60M | -14.34M | -13.66M | -12.71M | 24.43K | 522.48K | 2.02M | 929.87K | -1.90M | -9.12M |
| Net Change in Cash | -1.07M | 2.47M | -8.20M | -4.04M | 11.93M | 6.59M | 15.45M | 9.82M | 492.11K | -1.65M |
| Free Cash Flow | 17.18M | 17.62M | 6.02M | 9.22M | 10.78M | 5.37M | 9.86M | 7.15M | 2.64M | 8.63M |
This table shows 10 annual periods of iRadimed's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IRMD's reporting calendar. What is a cash flow statement?